PANEL 1 • 9:15-10:15am
Karyn is the VP of Major, Principal, and Planned Giving at March of Dimes and has been with the nonprofit since 2000. She has raised over $200M and secured some of the largest gifts from individuals in the history of the organization. Karyn led the March of Dimes California Chapter for several years, which was a top chapter in mission, advocacy, fundraising, communications, and operations. She then moved into the Major Gifts department and was asked to serve as the VP.
Debra Miller is CEO and Founder of CureDuchenne. She and her husband started the organization in 2002 after their only son, Hawken, was diagnosed with Duchenne. Debra and her team have brought many firsts to the Duchenne community, including a Duchenne-focused venture philanthropy model, an annual nationwide community education event tour (virtual for now), a Duchenne Physical Therapy Certification program and an open access Biobank. Debra proudly serves as the Patient Representative on TREAT-NMD’s Executive Committee and reviews Duchenne applications for the Department of Defense’s Congressionally Directed Medical Research Program.
Eunice is the Director, Impact for BrightEdge, the impact investment and venture capital arm of the American Cancer Society. Eunice is committed to sustainable values and focused on furthering the American Cancer Society’s mission through impact investing, venture capital, and innovative funding and financing structures. Prior to joining BrightEdge, Eunice served as the Chief Operating Officer and General Counsel for an ESG data start-up. She has multi-faceted expertise in domestic and global funds, investment products and ESG from her prior roles at prominent financial institutions, including Natixis Investment Managers, Bank of America/Merrill Lynch and State Street.
